Aclaris Therapeutics: Q4 Earnings Insights

Aclaris Therapeutics ACRS reported its Q4 earnings results on Tuesday, February 27, 2024 at 07:00 AM.

Here's what investors need to know about the announcement.

Earnings

Aclaris Therapeutics beat estimated earnings by 12.0%, reporting an EPS of $-0.3 versus an estimate of $-0.34.

Revenue was up $9.82 million from the same period last year.

Past Earnings Performance

Last quarter the company beat on EPS by $0.07 which was followed by a 1.0% drop in the share price the next day.

Here's a look at Aclaris Therapeutics's past performance:

Quarter Q3 2023 Q2 2023 Q1 2023 Q4 2022
EPS Estimate -0.48 -0.45 -0.44 -0.45
EPS Actual -0.41 -0.42 -0.42 -0.41
Revenue Estimate 1.57M 1.90M 1.75M 1.99M
Revenue Actual 9.28M 1.87M 2.53M 7.75M

To track all earnings releases for Aclaris Therapeutics visit their earnings calendar here.

This article was generated by Benzinga's automated content engine and reviewed by an editor.

Market News and Data brought to you by Benzinga APIs
Comments
Loading...
Date
ticker
name
Actual EPS
EPS Surprise
Actual Rev
Rev Surprise
Posted In: EarningsBZI-Recaps
Benzinga simplifies the market for smarter investing

Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.

Join Now: Free!